Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05527184
Title First in Human Study of IMGN151 in Recurrent Endometrial Cancer and Recurrent, High-grade Serous Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors ImmunoGen, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope RECRUITING Irvine California 92618 United States Details
UCLA RECRUITING Los Angeles California 90095 United States Details
University of Colorado Anschutz Cancer Pavilion RECRUITING Aurora Colorado 80045 United States Details
Florida Cancer Specialists RECRUITING Sarasota Florida 34232 United States Details
Karmanos Cancer Institute RECRUITING Detroit Michigan 48201 United States Details
Roswell Park Comprehensive Cancer Center RECRUITING Buffalo New York 14203 United States Details
OU Health Stephenson Cancer Center RECRUITING Oklahoma City Oklahoma 73104 United States Details
Tennessee Oncology Nashville RECRUITING Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field